PL2855487T3 - Związki do leczenia chorób powiązanych z niedokrwieniem-reperfuzją - Google Patents
Związki do leczenia chorób powiązanych z niedokrwieniem-reperfuzjąInfo
- Publication number
- PL2855487T3 PL2855487T3 PL13721085T PL13721085T PL2855487T3 PL 2855487 T3 PL2855487 T3 PL 2855487T3 PL 13721085 T PL13721085 T PL 13721085T PL 13721085 T PL13721085 T PL 13721085T PL 2855487 T3 PL2855487 T3 PL 2855487T3
- Authority
- PL
- Poland
- Prior art keywords
- reperfusion
- ischemia
- compounds
- treatment
- related diseases
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 208000028867 ischemia Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/886—Streptomyces
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Neurosurgery (AREA)
- Surgery (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000062A ITFI20120062A1 (it) | 2012-03-21 | 2012-03-21 | Componenti per il trattamento di malattie correlate a ischemia-riperfusione. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2855487T3 true PL2855487T3 (pl) | 2017-02-28 |
Family
ID=46147570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13721085T PL2855487T3 (pl) | 2012-03-21 | 2013-03-20 | Związki do leczenia chorób powiązanych z niedokrwieniem-reperfuzją |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US9932352B2 (pl) |
| EP (1) | EP2855487B1 (pl) |
| JP (2) | JP6382791B2 (pl) |
| KR (2) | KR20150014910A (pl) |
| CN (1) | CN104395321B (pl) |
| AU (2) | AU2013237021B2 (pl) |
| CA (1) | CA2907652C (pl) |
| CY (1) | CY1118282T1 (pl) |
| DK (1) | DK2855487T3 (pl) |
| EA (1) | EA033160B1 (pl) |
| ES (1) | ES2601384T3 (pl) |
| HR (1) | HRP20161436T1 (pl) |
| HU (1) | HUE031535T2 (pl) |
| IL (1) | IL234796B (pl) |
| IN (1) | IN2014CH07744A (pl) |
| IT (1) | ITFI20120062A1 (pl) |
| LT (1) | LT2855487T (pl) |
| ME (1) | ME02553B (pl) |
| PL (1) | PL2855487T3 (pl) |
| PT (1) | PT2855487T (pl) |
| RS (1) | RS55337B1 (pl) |
| SI (1) | SI2855487T1 (pl) |
| SM (2) | SMT201700055T1 (pl) |
| WO (1) | WO2013140348A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013082458A1 (en) | 2011-12-02 | 2013-06-06 | The Regents Of The University Of California | Reperfusion protection solution and uses thereof |
| IT202000008125A1 (it) | 2020-04-16 | 2021-10-16 | Minerva Srl | Acidi carbossilici 3-aza-biciclo[3.2.1]ottani e loro derivati per l’uso nel trattamento di infiammazioni |
| IT202200016614A1 (it) | 2022-08-04 | 2024-02-04 | Mimetech S R L | Udonitrectag e sue formulazioni ad uso topico per l’uso nel trattamento di patologie dermatologiche |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR75910B (pl) | 1981-04-21 | 1984-08-02 | Delalande Sa | |
| DE60042585D1 (de) | 2000-02-29 | 2009-09-03 | Univ Firenze | 3-Aza-6,8-dioxabicycloÄ3.2.1Üoctane und Analoga sowie diese enthaltende kombinatorische Bibliotheken |
| ITFI20020107A1 (it) * | 2002-06-19 | 2003-12-19 | Antonio Guarna | Composizioni farmaceutiche atte all'uso nel trattamento di patologie correlate all'azione di neutrofine e composti attivi in esse contenuti |
| JP2005533845A (ja) * | 2002-07-18 | 2005-11-10 | ファイザー・プロダクツ・インク | Ccr1ケモカインレセプターのアンタゴニストとしての二環式ピペリジン誘導体 |
| WO2006015183A2 (en) * | 2004-07-30 | 2006-02-09 | Axonyx, Inc. | Pharmaceutical compositions for treating disorders of the skin |
| EP2189462B9 (en) * | 2008-11-25 | 2012-06-13 | Universita' Degli Studi di Firenze | Bicyclic peptidomimetic inhibitors of aspartyl-proteases for the treatment of infectious diseases |
-
2012
- 2012-03-21 IT IT000062A patent/ITFI20120062A1/it unknown
-
2013
- 2013-03-20 CA CA2907652A patent/CA2907652C/en active Active
- 2013-03-20 SI SI201330411A patent/SI2855487T1/sl unknown
- 2013-03-20 RS RS20160926A patent/RS55337B1/sr unknown
- 2013-03-20 PT PT137210852T patent/PT2855487T/pt unknown
- 2013-03-20 ES ES13721085.2T patent/ES2601384T3/es active Active
- 2013-03-20 DK DK13721085.2T patent/DK2855487T3/en active
- 2013-03-20 ME MEP-2016-251A patent/ME02553B/me unknown
- 2013-03-20 HU HUE13721085A patent/HUE031535T2/en unknown
- 2013-03-20 US US14/387,015 patent/US9932352B2/en active Active
- 2013-03-20 CN CN201380026577.3A patent/CN104395321B/zh active Active
- 2013-03-20 AU AU2013237021A patent/AU2013237021B2/en active Active
- 2013-03-20 SM SM20170055T patent/SMT201700055T1/it unknown
- 2013-03-20 KR KR1020147029365A patent/KR20150014910A/ko not_active Ceased
- 2013-03-20 LT LTEP13721085.2T patent/LT2855487T/lt unknown
- 2013-03-20 EP EP13721085.2A patent/EP2855487B1/en active Active
- 2013-03-20 PL PL13721085T patent/PL2855487T3/pl unknown
- 2013-03-20 HR HRP20161436TT patent/HRP20161436T1/hr unknown
- 2013-03-20 EA EA201401045A patent/EA033160B1/ru unknown
- 2013-03-20 JP JP2015501034A patent/JP6382791B2/ja active Active
- 2013-03-20 WO PCT/IB2013/052205 patent/WO2013140348A1/en not_active Ceased
- 2013-03-20 KR KR1020207012664A patent/KR102181346B1/ko active Active
-
2014
- 2014-09-22 IL IL234796A patent/IL234796B/en active IP Right Grant
- 2014-10-21 IN IN7744CH2014 patent/IN2014CH07744A/en unknown
-
2016
- 2016-11-03 CY CY20161101112T patent/CY1118282T1/el unknown
-
2017
- 2017-01-25 SM SM201700055T patent/SMT201700055B/it unknown
- 2017-11-21 AU AU2017265037A patent/AU2017265037B2/en active Active
- 2017-12-12 US US15/839,148 patent/US20180155363A1/en not_active Abandoned
-
2018
- 2018-06-27 JP JP2018122052A patent/JP2018168173A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL237275A0 (en) | Compounds for the treatment of paramoxovirus viral infections | |
| ZA201402424B (en) | 1- arylcarbonyl -4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases | |
| LT2925757T (lt) | Junginiai ir kompozicijos, skirti parazitinių ligų gydymui | |
| GB201021103D0 (en) | New compounds for the treatment of neurodegenerative diseases | |
| ZA201501390B (en) | Compounds for the treatment of mtor pathway related diseases | |
| EP2994460A4 (en) | Compounds for treatment of angiogenesis-mediated diseases | |
| IL243637B (en) | PPAR-sparing compounds for the treatment of metabolic diseases | |
| ZA201305970B (en) | Arylosulfonami for the treatment of cns diseases | |
| SG11201404649UA (en) | Novel compounds for the treatment of dyslipidemia and related diseases | |
| IL239273A0 (en) | A method of treating diseases | |
| IL238592B (en) | Compounds for treatment of liver diseases | |
| PL2855475T3 (pl) | Alfa-karboliny do leczenia nowotworu | |
| HUP1100290A2 (en) | Combination compositions for the treatment of proliferative diseases | |
| IL234796B (en) | Compounds for the treatment of diseases related to ischemia-reperfusion | |
| IL236873A0 (en) | therapeutic compounds | |
| GB201217331D0 (en) | Novel compound useful for the treatment of infectious diseases | |
| GB201207359D0 (en) | Compounds for the treatment of metabolic disorders | |
| GB201207363D0 (en) | Compounds for the treatment of metabolic disorders | |
| GB201204645D0 (en) | Treatment of disease | |
| GB201106981D0 (en) | Compounds for the treatment of clostridium difficle-associated disease | |
| GB201207476D0 (en) | pharmaceutical for the treatment of leishmaniasis | |
| IL232294A0 (en) | Preparations for the treatment of diabetes | |
| GB201215527D0 (en) | Compounds for the treatment of muscular dystrophy | |
| GB201119533D0 (en) | Compounds for the treatment of neoplasia |